Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients | 09/09/2022 - 09/09/2022 | France, Paris | Website | Oncology | PVI, PeerView Institute for Medical Education | 0.0 European CME credits (ECMEC®) |
